Part I: Significant reduction of lyophilization process times by using novel matrix based scaffolds
[Display omitted] To improve the long-term stability of drugs with limited stability (e.g., biologicals such as monoclonal antibodies, antibody drug conjugates or peptides), some pharmaceuticals endure a lengthy and cost-intensive process called lyophilization. While the shelf life of lyophilized dr...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutics and biopharmaceutics 2023-03, Vol.184, p.248-261 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!